News | September 24, 2024
Devyser to share data at ASHI 2024 demonstrating its innovations and studies within transplantation
Find out more
All articles
.png)
New insights into thalassemia: Latest studies using Devyser Thalassemia for NGS testing
.png)
Devyser Diagnostics AB publishes quarterly report for the period April to June 2024
“Devyser continued to report high sales growth in the second quarter. Organic growth compared with...
.png)
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
.png)
Meeting Modern Demands: Overcoming Thalassemia Testing Challenges with NGS
.png)
One-size-fits-all: Addressing hemoglobinopathy using NGS
.png)
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
.png)
Streamlining Thalassemia Genetic Testing with NGS: Insights from Cyprus
Devyser announces expanded commercial agreement with Thermo Fisher Scientific for post-transplant monitoring NGS products
Devyser launches updated Y-Chromosomal microdeletion test
Devyser wins all-time high tender for up to 75 MSEK
.png)